SBF2-AS1 and TreRNA: novel lncRNA players in triple-negative breast cancer pathogenesis.
Zeeba KamaliyanKimia DorrajiSetare KakavandGhasem Azizi-TabeshNikta MirfakhraieRamesh OmranipourNasrin AhmadinejadVahid-Reza YassaeeReza MirfakhraiePublished in: Molecular biology reports (2023)
Due to the differential expression and the potential diagnostic power of the studied genes, SBF2-AS1 and treRNA can be proposed as new probable biomarkers and therapeutic targets in TNBC.